These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 25767435)

  • 21. Single-Nucleotide Mutations in FMR1 Reveal Novel Functions and Regulatory Mechanisms of the Fragile X Syndrome Protein FMRP.
    Suhl JA; Warren ST
    J Exp Neurosci; 2015; 9(Suppl 2):35-41. PubMed ID: 26819560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuro-Inflammatory Mechanisms in Developmental Disorders Associated with Intellectual Disability and Autism Spectrum Disorder: A Neuro- Immune Perspective.
    Di Marco B; Bonaccorso CM; Aloisi E; D'Antoni S; Catania MV
    CNS Neurol Disord Drug Targets; 2016; 15(4):448-63. PubMed ID: 26996174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, molecular, and pharmacological aspects of FMR1 related disorders.
    Pugin A; Faundes V; Santa María L; Curotto B; Aliaga S; Salas I; Soto P; Bravo P; Peña MI; Alliende MA
    Neurologia; 2017 May; 32(4):241-252. PubMed ID: 25529181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Autism and epigenetics. A model of explanation for the understanding of the genesis in autism spectrum disorders].
    Arberas C; Ruggieri V
    Medicina (B Aires); 2013; 73 Suppl 1():20-9. PubMed ID: 24072048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diet in treatment of autism spectrum disorders.
    Alam S; Westmark CJ; McCullagh EA
    Front Neurosci; 2022; 16():1031016. PubMed ID: 37492195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of autistic spectrum disorder with insulin-like growth factors.
    Riikonen R
    Eur J Paediatr Neurol; 2016 Nov; 20(6):816-823. PubMed ID: 27562096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FMRP Expression Levels in Mouse Central Nervous System Neurons Determine Behavioral Phenotype.
    Arsenault J; Gholizadeh S; Niibori Y; Pacey LK; Halder SK; Koxhioni E; Konno A; Hirai H; Hampson DR
    Hum Gene Ther; 2016 Dec; 27(12):982-996. PubMed ID: 27604541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From de novo mutations to personalized therapeutic interventions in autism.
    Brandler WM; Sebat J
    Annu Rev Med; 2015; 66():487-507. PubMed ID: 25587659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does microglial dysfunction play a role in autism and Rett syndrome?
    Maezawa I; Calafiore M; Wulff H; Jin LW
    Neuron Glia Biol; 2011 Feb; 7(1):85-97. PubMed ID: 22717189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The psychopharmacology of autism spectrum disorder and Rett syndrome.
    Persico AM; Ricciardello A; Cucinotta F
    Handb Clin Neurol; 2019; 165():391-414. PubMed ID: 31727226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling fragile X syndrome in the laboratory setting: A behavioral perspective.
    Melancia F; Trezza V
    Behav Brain Res; 2018 Sep; 350():149-163. PubMed ID: 29704597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin for Treatment of Fragile X Syndrome and Other Neurological Disorders.
    Gantois I; Popic J; Khoutorsky A; Sonenberg N
    Annu Rev Med; 2019 Jan; 70():167-181. PubMed ID: 30365357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurological manifestation and genetic diagnosis of Angelman, Rett and Fragile-X syndromes].
    Veiga MF; Toralles MB
    J Pediatr (Rio J); 2002 Jul; 78 Suppl 1():S55-62. PubMed ID: 14676869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid rafts: a signaling platform linking cholesterol metabolism to synaptic deficits in autism spectrum disorders.
    Wang H
    Front Behav Neurosci; 2014; 8():104. PubMed ID: 24723866
    [No Abstract]   [Full Text] [Related]  

  • 35. Prefrontal Cortex Dysfunction in Fragile X Mice Depends on the Continued Absence of Fragile X Mental Retardation Protein in the Adult Brain.
    Siegel JJ; Chitwood RA; Ding JM; Payne C; Taylor W; Gray R; Zemelman BV; Johnston D
    J Neurosci; 2017 Aug; 37(31):7305-7317. PubMed ID: 28652410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The overlapping spectrum of rett and angelman syndromes: a clinical review.
    Jedele KB
    Semin Pediatr Neurol; 2007 Sep; 14(3):108-17. PubMed ID: 17980307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological Treatments for Fragile X Syndrome Based on Synaptic Dysfunction.
    Telias M
    Curr Pharm Des; 2019; 25(41):4394-4404. PubMed ID: 31682210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status of biological treatment options in Autism Spectrum Disorder.
    Eapen V; Nicholls L; Spagnol V; Mathew NE
    Asian J Psychiatr; 2017 Dec; 30():1-10. PubMed ID: 28704714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism.
    Huber KM; Klann E; Costa-Mattioli M; Zukin RS
    J Neurosci; 2015 Oct; 35(41):13836-42. PubMed ID: 26468183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MeCP2 dysfunction in Rett syndrome and related disorders.
    Moretti P; Zoghbi HY
    Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.